Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction
Breast cancer remains the most diagnosed cancer in women. Advances in medical imaging
modalities and technologies have greatly aided in the early detection of breast cancer and …
modalities and technologies have greatly aided in the early detection of breast cancer and …
Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a …
L Tang, X Shu, G Tu - World Journal of Surgical Oncology, 2022 - Springer
Background Pathological complete response (pCR) is the goal of neoadjuvant
chemotherapy (NACT). We aimed to develop a nomogram to predict the probability of …
chemotherapy (NACT). We aimed to develop a nomogram to predict the probability of …
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy
E Değerli, N Şentürk Öztaş, G Alkan, Ş Bedir… - Journal of …, 2023 - Taylor & Francis
Majority of patients with breast cancer were diagnosed with locally advanced stages of the
disease (54%). This study aimed to explain the pathological response received to …
disease (54%). This study aimed to explain the pathological response received to …
[PDF][PDF] The value of potential immunohistochemical biomarkers and clinicopathological findings in predicting response to neoadjuvant chemotherapy in breast cancer.
OBJECTIVE: Following neoadjuvant chemotherapy (NAC) in breast cancer (BC), complete
treatment response is achieved in some patients, while treatment response is limited in …
treatment response is achieved in some patients, while treatment response is limited in …
[HTML][HTML] CD10 expression as a potential predictor of pathological complete response in ER-negative and triple-negative breast cancer patients treated with …
G Dimitrov, S Shousha, P Troianova - Experimental and Molecular …, 2024 - Elsevier
Background Neoadjuvant chemotherapy (NCT) can induce a pathological complete
response (pCR) in breast cancer patients, leading to improved outcomes. However …
response (pCR) in breast cancer patients, leading to improved outcomes. However …
Can peritumoral edema evaluated by Magnetic Resonance Imaging before neoadjuvant chemotherapy predict complete pathological response in breast cancer?
B Cakir Pekoz, O Dilek, T Koseci… - Scottish Medical …, 2023 - journals.sagepub.com
Background and Aims The complete pathological response (pCR) following neoadjuvant
chemotherapy (NAC) in breast cancer is essential for the accurate prediction of prognosis …
chemotherapy (NAC) in breast cancer is essential for the accurate prediction of prognosis …
[HTML][HTML] Predictive factors for complete pathological response in hormone receptor-negative breast cancer patients undergoing neoadjuvant chemotherapy
G Dimitrov, P Troianova - Pathology-Research and Practice, 2024 - Elsevier
Complete pathological response (pCR) is a pivotal predictor of enhanced disease-free and
overall survival rates in breast cancer patients. Accurate prediction of pCR is therefore of …
overall survival rates in breast cancer patients. Accurate prediction of pCR is therefore of …
Role of Tumor Subtypes in Response to Neoadjuvant Chemotherapy in Non-metastatic Breast Cancer
N Mashoori, R Omranipour… - Archives of Iranian …, 2021 - journalaim.com
Background: Neoadjuvant chemotherapy (NAC) is an integral part of breast cancer
treatment. Determination of the factors that can distinguish patients who will have best …
treatment. Determination of the factors that can distinguish patients who will have best …
Predictive value of Ki67 for complete pathological response to neoadjuvant chemotherapy in patients with breast cancer
SMM Abd El Khalek, MQR Mohammed… - Egyptian Journal of …, 2021 - journals.lww.com
Background Neoadjuvant chemotherapy is an essential therapeutic approach for patients
with breast cancer, with the goal of improving pathological complete response rate (pCR) by …
with breast cancer, with the goal of improving pathological complete response rate (pCR) by …
[PDF][PDF] Role of Tumor Subtypes in Response to Neoadjuvant Chemotherapy in Non-metastatic Breast Cancer
MD Negar Mashoori, MD Ramesh Omranipour… - sid.ir
Background: Neoadjuvant chemotherapy (NAC) is an integral part of breast cancer
treatment. Determination of the factors that can distinguish patients who will have best …
treatment. Determination of the factors that can distinguish patients who will have best …